RxDoctor Payments Data

Todd Meyer, DO

Otolaryngology/Facial Plastic Surgery · Appleton, WINPI 1306863014

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (56.2%), food and beverage and education — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Stryker at 44.2% of the total. 2025 is the largest year on record at $2,449, more than ten times the $201 reported in 2019.

$4,615in general payments, 2019–2025

Across 59 payments — averaging $78.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Inspire Medical Systems, Inc.$1K
  • Sanofi$421
  • Acclarent, Inc$367
  • Intersect ENT, Inc.$255
  • Aerin Medical Inc.$153
  • plus $324 from 6 others

What the payments were for

  • Travel & lodging$2,59556%
  • Food & beverage$1,98543%
  • Education$341%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otolaryngology/facial plastic surgery providers in Wisconsinto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$43,878
Medicare patients
99
Services billed
1,070

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab36$147,841
Epinephrine37$9,238
Ipratropium Bromide74$2,576
Fluticasone Propionate128$1,311
Montelukast Sodium54$794
Azelastine Hcl25$734
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen12$52

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Appleton

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →